Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics
Targeted therapy is an emerging paradigm in the development of next-generation anticancer drugs. Heat shock factor 1 (HSF1) has been identified as a promising drug target because it regulates several pathways responsible for cancer cell growth, metastasis, and survival. Studies have clearly demonstr...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/23/11/2757 |
_version_ | 1819080142460289024 |
---|---|
author | Chiranjeev Sharma Young Ho Seo |
author_facet | Chiranjeev Sharma Young Ho Seo |
author_sort | Chiranjeev Sharma |
collection | DOAJ |
description | Targeted therapy is an emerging paradigm in the development of next-generation anticancer drugs. Heat shock factor 1 (HSF1) has been identified as a promising drug target because it regulates several pathways responsible for cancer cell growth, metastasis, and survival. Studies have clearly demonstrated that HSF1 is an effective drug target. Herein, we provide a concise yet comprehensive and integrated overview of progress in developing small molecule inhibitors of HSF1 as next-generation anticancer chemotherapeutics while critically evaluating their potential and challenges. We believe that this review will provide a better understanding of important concepts helpful for outlining the strategy to develop new chemotherapeutic agents with promising anticancer activities by targeting HSF1. |
first_indexed | 2024-12-21T19:40:11Z |
format | Article |
id | doaj.art-b922eb3ce4d44da7901fbe038c2cdf31 |
institution | Directory Open Access Journal |
issn | 1420-3049 |
language | English |
last_indexed | 2024-12-21T19:40:11Z |
publishDate | 2018-10-01 |
publisher | MDPI AG |
record_format | Article |
series | Molecules |
spelling | doaj.art-b922eb3ce4d44da7901fbe038c2cdf312022-12-21T18:52:30ZengMDPI AGMolecules1420-30492018-10-012311275710.3390/molecules23112757molecules23112757Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer TherapeuticsChiranjeev Sharma0Young Ho Seo1College of Pharmacy, Keimyung University, Daegu 42601, KoreaCollege of Pharmacy, Keimyung University, Daegu 42601, KoreaTargeted therapy is an emerging paradigm in the development of next-generation anticancer drugs. Heat shock factor 1 (HSF1) has been identified as a promising drug target because it regulates several pathways responsible for cancer cell growth, metastasis, and survival. Studies have clearly demonstrated that HSF1 is an effective drug target. Herein, we provide a concise yet comprehensive and integrated overview of progress in developing small molecule inhibitors of HSF1 as next-generation anticancer chemotherapeutics while critically evaluating their potential and challenges. We believe that this review will provide a better understanding of important concepts helpful for outlining the strategy to develop new chemotherapeutic agents with promising anticancer activities by targeting HSF1.https://www.mdpi.com/1420-3049/23/11/2757HSF1HSPsHSF1 inhibitorsanticancer agents |
spellingShingle | Chiranjeev Sharma Young Ho Seo Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics Molecules HSF1 HSPs HSF1 inhibitors anticancer agents |
title | Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics |
title_full | Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics |
title_fullStr | Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics |
title_full_unstemmed | Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics |
title_short | Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics |
title_sort | small molecule inhibitors of hsf1 activated pathways as potential next generation anticancer therapeutics |
topic | HSF1 HSPs HSF1 inhibitors anticancer agents |
url | https://www.mdpi.com/1420-3049/23/11/2757 |
work_keys_str_mv | AT chiranjeevsharma smallmoleculeinhibitorsofhsf1activatedpathwaysaspotentialnextgenerationanticancertherapeutics AT younghoseo smallmoleculeinhibitorsofhsf1activatedpathwaysaspotentialnextgenerationanticancertherapeutics |